Skip to content

Clinical trials

Phase 3 Lymphoma, Large B-Cell, Diffuse trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 3 Country / region: Russia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20113
20121
20133
20152
20171
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
Janssen Research & Development, LLC2
Acerta Pharma BV1
Arbeitsgemeinschaft medikamentoese Tumortherapie1
CTI BioPharma1
Celgene1
Genmab1
GlaxoSmithKline1
Incyte Corporation1
National Research Center for Hematology, Russia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse16
Lymphoma4
Lymphoma, Non-Hodgkin4
Lymphoma, B-Cell3
Lymphoma, Follicular2
Neoplasms2
Recurrence2
Bronchiolitis Obliterans Syndrome1
Hematologic Neoplasms1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.